600+ sources. One page. See who else covered it.
Pharmaceutical laboratories Novo Nordisk and Eli Lilly are betting on oral forms of their weight-loss products, driven by the success of their injectable version. After a successful launch in the United States, they are preparing to distribute them in many countries.
We haven't written up this one. Le Monde Economie has the full story — the link below goes straight to it.
As the boom in trophy timepieces cools, a new generation of enthusiasts is fuelling demand for accessible watches that deliver strong design, quality and heritage, made by brands ranging from Casio to…
Every time someone hops out of a Grab without touching their wallet, or taps “pay later” on a Shopee checkout, they are using a piece of financial infrastructure they never consciously chose.
In the short term, urgent transports are to be diverted by road and rail. In the Rhine catchment area alone, production losses of around €913 million could threaten this summer.
MOM expects wage growth to remain positive